Related Experiment Video
Updated: Oct 22, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Increased Expression of Cardiotrophin-1 in Cardiomyopathy Patients
1Department of Zoology, Lahore College for Women University, Lahore, Pakistan.
Insights
Cardiotrophin-1 (CT-1) levels are significantly elevated in cardiomyopathy (CM) patients. This cardiac dysfunction marker
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Cardiomyopathy (CM) is a significant cause of mortality.
- Both genetic and environmental factors contribute to CM.
- Cardiotrophin-1 (CT-1) plasma levels are linked to CM and affect cardiomyocyte differentiation.
Purpose of the Study:
- To evaluate the expression of Cardiotrophin-1 (CT-1) in patients with cardiomyopathy (CM).
Main Methods:
- Study included 40 subjects (20 CM, 20 controls) from January to June 2016.
- Data collected via questionnaire (age, BMI, CM history).
- RNA isolated from blood, converted to cDNA, and CT-1 expression analyzed using reverse-transcriptase-polymerase chain reaction (RT-PCR).
Main Results:
- Mean age of CM subjects was 40.1±6.03 years; controls were 35.0±3.7 years.
- Mean CT-1 expression was 5.2±0.66 in CM subjects versus 1.00±0.001 in controls.
- CT-1 expression showed a significant difference in the CM group and correlated with age and BMI.
Conclusions:
- Cardiotrophin-1 (CT-1) expression is significantly higher in cardiomyopathy patients.
- CT-1 expression is correlated with age and BMI in individuals with CM.
- Findings suggest CT-1 as a potential biomarker for cardiomyopathy.
Abstract:
Cardiomyopathy (CM) is a condition of cardiac dysfunction. It is one of the leading causes of mortality in which both genetic and environmental factors are involved. Cardiotrophin-1 (CT-1) level in plasma is associated with CM. It affects the cardiomyocyte differentiation. To evaluate the expression of CT-1 in cardiomyopathy, this study was done on CM subjects attending the Fatima Memorial Hospital, Lahore, Pakistan, between January and June, 2016. A total of 40 subjects were enrolled who were divided into two groups; CM group (n = 20) and a control group (n = 20). A self-designed questionnaire was filled in by each subject to collect data regarding age, body mass index (BMI) and CM history. RNA was isolated from blood after its quantification, cDNA was prepared and reverse-transcriptase-polymerase chain reaction (RT-PCR) was performed for expression of CT-1. The mean age in CM subjects was 40.1±6.03 years, while it was 35.0±3.7 years in the control group. The mean expression of CT-1 in the CM subjects was 5.2±0.66, while it was 1.00±0.001 in the control group. A highly significant difference was observed in CT-1 expression in the CM group, and expression was significantly correlated with age and BMI in CM subjects.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care

